Accelerating Cervical Cancer Elimination by Self-Sampling test
Not Applicable
- Conditions
- cervical cancerD002583
- Registration Number
- JPRN-jRCT1030200276
- Lead Sponsor
- Hata Akira
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Female
- Target Recruitment
- 20000
Inclusion Criteria
1. Female residents of Ichihara City at the time of extraction
2. Target residents for cervical cancer screening in the fiscal year 2021 (even-numbered age)
3. Residents aged 30 years to 59 years at the point of April 1 in 2021
4. Residents who have not participated in the screening by Ichihara City for more than three years
Exclusion Criteria
1. Residents with unknown address
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Detection of cervical intraepithelial neoplasia (CIN) 2 or worse
- Secondary Outcome Measures
Name Time Method Screening uptake<br>Subjects who have received cytology test<br>Subjects required for detaied test<br>Subjects who have received detailed tests<br>Detection of CIN2 or worse per one cytology test<br>Positive predictive values<br>Incidence of adverse events<br>Proportion of self-sampling HPV test ordered<br>Proportion of self-sampking HPV test ordered from the web site<br>Proportion of self-sampling HPV test received<br>Proportion of positive HPV test<br>Proportion of invalid HPV test<br>Proportion of cytology test received<br>Time to the self-sampling HPV test ordered<br>Time to the self-sampling HPV kit sent to the subjects<br>Time to the self-sampling HPV kit returned from the subjects<br>Time to HPV test ordered to the laboratory<br>TIme to HPV test result reported from the laboratory<br>Time to HPV test result sent to the subjects<br>Total time<br>Questionnaire survey<br>Screening uptake in 2023